ProfileGDS5678 / 1424742_at
TitleAnti-VEGF and Anti-Notch treatment effect on U87 glioblastoma xenograft tumors [Mouse430_2]
OrganismMus musculus


control bevacizumab dibenzazepine GSM967852 GSM967853 GSM967854 GSM967855 GSM967856 GSM967862 GSM967863 GSM967864 GSM967865 GSM967857 GSM967858 GSM967859 GSM967860 GSM967861 29% 31% 30% 29% 30% 31% 30% 30% 31% 31% 30% 31% 30% 30% sort by agent Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM967852U87-EV human glioblastoma xenograft - Control 12.7024329
GSM967853U87-EV human glioblastoma xenograft - Control 22.6969331
GSM967854U87-EV human glioblastoma xenograft - Control 32.6914730
GSM967855U87-EV human glioblastoma xenograft - Control 42.6193829
GSM967856U87-EV human glioblastoma xenograft - Control 52.6417630
GSM967862U87-EV human glioblastoma xenograft - Bevacizumab treated 12.7851331
GSM967863U87-EV human glioblastoma xenograft - Bevacizumab treated 22.7396330
GSM967864U87-EV human glioblastoma xenograft - Bevacizumab treated 32.6644130
GSM967865U87-EV human glioblastoma xenograft - Bevacizumab treated 42.6736831
GSM967857U87-EV human glioblastoma xenograft - dibenzazepine treated 12.6850631
GSM967858U87-EV human glioblastoma xenograft - dibenzazepine treated 22.6773330
GSM967859U87-EV human glioblastoma xenograft - dibenzazepine treated 32.669431
GSM967860U87-EV human glioblastoma xenograft - dibenzazepine treated 42.6898730
GSM967861U87-EV human glioblastoma xenograft - dibenzazepine treated 52.6827830